|
Volumn 54, Issue 5, 2006, Pages 861-
|
Perioperative haloperidol to prevent postoperative delirium [7]
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HALOPERIDOL;
LORAZEPAM;
NEUROLEPTIC AGENT;
ANXIOLYTIC AGENT;
ALCOHOL WITHDRAWAL;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DELIRIUM;
DEMENTIA;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG SAFETY;
HEART MUSCLE ISCHEMIA;
HUMAN;
INCIDENCE;
LETTER;
LOW DRUG DOSE;
MORTALITY;
ORTHOPEDIC SURGERY;
PERIOPERATIVE PERIOD;
POSTOPERATIVE COMPLICATION;
QT INTERVAL;
RISK REDUCTION;
SAMPLE SIZE;
TREATMENT INDICATION;
AGED;
DOSE RESPONSE;
DRUG COMBINATION;
NOTE;
AGED;
ANTI-ANXIETY AGENTS;
ANTIPSYCHOTIC AGENTS;
DELIRIUM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
HALOPERIDOL;
HUMANS;
LORAZEPAM;
PERIOPERATIVE CARE;
POSTOPERATIVE COMPLICATIONS;
|
EID: 33744987160
PISSN: 00028614
EISSN: 15325415
Source Type: Journal
DOI: 10.1111/j.1532-5415.2006.00714.x Document Type: Letter |
Times cited : (6)
|
References (5)
|